282 related articles for article (PubMed ID: 22176384)
1. Short-term stability of subtypes in the irritable bowel syndrome: prospective evaluation using the Rome III classification.
Engsbro AL; Simren M; Bytzer P
Aliment Pharmacol Ther; 2012 Feb; 35(3):350-9. PubMed ID: 22176384
[TBL] [Abstract][Full Text] [Related]
2. Subtyping the irritable bowel syndrome by predominant bowel habit: Rome II versus Rome III.
Ersryd A; Posserud I; Abrahamsson H; Simrén M
Aliment Pharmacol Ther; 2007 Sep; 26(6):953-61. PubMed ID: 17767480
[TBL] [Abstract][Full Text] [Related]
3. Subtypes of irritable bowel syndrome on Rome III criteria: a multicenter study.
Yao X; Yang YS; Cui LH; Zhao KB; Zhang ZH; Peng LH; Guo X; Sun G; Shang J; Wang WF; Feng J; Huang Q
J Gastroenterol Hepatol; 2012 Apr; 27(4):760-5. PubMed ID: 21929652
[TBL] [Abstract][Full Text] [Related]
4. Change over time of bowel habit in irritable bowel syndrome: a prospective, observational, 1-year follow-up study (RITMO study).
Garrigues V; Mearin F; Badía X; Balboa A; Benavent J; Caballero A; Domínguez E; Díaz-Rubio M; Roset M; Figueras M; Cucala M;
Aliment Pharmacol Ther; 2007 Feb; 25(3):323-32. PubMed ID: 17217445
[TBL] [Abstract][Full Text] [Related]
5. Incidence of post-infectious irritable bowel syndrome and functional intestinal disorders following a water-borne viral gastroenteritis outbreak.
Zanini B; Ricci C; Bandera F; Caselani F; Magni A; Laronga AM; Lanzini A;
Am J Gastroenterol; 2012 Jun; 107(6):891-9. PubMed ID: 22525306
[TBL] [Abstract][Full Text] [Related]
6. Importance of diarrhea in evaluating constipation in irritable bowel syndrome clinical studies.
Basseri RJ; Kunkel D; Low K; Conklin JL; Pimentel M
J Clin Gastroenterol; 2011 Oct; 45(9):790-3. PubMed ID: 21301356
[TBL] [Abstract][Full Text] [Related]
7. Subtypes of irritable bowel syndrome in children: prevalence at diagnosis and at follow-up.
Giannetti E; de'Angelis G; Turco R; Campanozzi A; Pensabene L; Salvatore S; de Seta F; Staiano A
J Pediatr; 2014 May; 164(5):1099-1103.e1. PubMed ID: 24485818
[TBL] [Abstract][Full Text] [Related]
8. Characterization of the alternating bowel habit subtype in patients with irritable bowel syndrome.
Tillisch K; Labus JS; Naliboff BD; Bolus R; Shetzline M; Mayer EA; Chang L
Am J Gastroenterol; 2005 Apr; 100(4):896-904. PubMed ID: 15784038
[TBL] [Abstract][Full Text] [Related]
9. Characteristics of acute pain attacks in patients with irritable bowel syndrome meeting Rome III criteria.
Hellström PM; Saito YA; Bytzer P; Tack J; Mueller-Lissner S; Chang L
Am J Gastroenterol; 2011 Jul; 106(7):1299-307. PubMed ID: 21448146
[TBL] [Abstract][Full Text] [Related]
10. Symptomatic efficacy of beidellitic montmorillonite in irritable bowel syndrome: a randomized, controlled trial.
Ducrotte P; Dapoigny M; Bonaz B; Siproudhis L
Aliment Pharmacol Ther; 2005 Feb; 21(4):435-44. PubMed ID: 15709995
[TBL] [Abstract][Full Text] [Related]
11. The Rome II and Rome III criteria identify the same subtype-populations in irritable bowel syndrome: agreement depends on the method used for symptom report.
Engsbro AL; Simrén M; Bytzer P
Neurogastroenterol Motil; 2012 Jul; 24(7):604-11, e266. PubMed ID: 22420629
[TBL] [Abstract][Full Text] [Related]
12. Colonic transit time and IBS symptoms: what's the link?
Törnblom H; Van Oudenhove L; Sadik R; Abrahamsson H; Tack J; Simrén M
Am J Gastroenterol; 2012 May; 107(5):754-60. PubMed ID: 22334251
[TBL] [Abstract][Full Text] [Related]
13. Irritable bowel syndrome subtypes defined by Rome II and Rome III criteria are similar.
Dorn SD; Morris CB; Hu Y; Toner BB; Diamant N; Whitehead WE; Bangdiwala SI; Drossman DA
J Clin Gastroenterol; 2009 Mar; 43(3):214-20. PubMed ID: 19623100
[TBL] [Abstract][Full Text] [Related]
14. [A comparison between Rome III and Rome II criteria in diagnosing irritable bowel syndrome].
Wang AJ; Liao XH; Hu PJ; Liu SC; Xiong LS; Chen MH
Zhonghua Nei Ke Za Zhi; 2007 Aug; 46(8):644-7. PubMed ID: 17967234
[TBL] [Abstract][Full Text] [Related]
15. An examination of subgroup classification in irritable bowel syndrome patients over time: a prospective study.
Penny KI; Smith GD; Ramsay D; Steinke DT; Kinnear M; Penman ID
Int J Nurs Stud; 2008 Dec; 45(12):1715-20. PubMed ID: 18829027
[TBL] [Abstract][Full Text] [Related]
16. Characterization of episodes of irritable bowel syndrome using ecological momentary assessment.
Weinland SR; Morris CB; Hu Y; Leserman J; Bangdiwala SI; Drossman DA
Am J Gastroenterol; 2011 Oct; 106(10):1813-20. PubMed ID: 21647206
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and tolerability of alosetron for the treatment of irritable bowel syndrome in women and men: a meta-analysis of eight randomized, placebo-controlled, 12-week trials.
Rahimi R; Nikfar S; Abdollahi M
Clin Ther; 2008 May; 30(5):884-901. PubMed ID: 18555935
[TBL] [Abstract][Full Text] [Related]
18. Irritable bowel syndrome: a population based study.
Khoshkrood-Mansoori B; Pourhoseingholi MA; Safaee A; Moghimi-Dehkordi B; Sedigh-Tonekaboni B; Pourhoseingholi A; Habibi M; Zali MR
J Gastrointestin Liver Dis; 2009 Dec; 18(4):413-8. PubMed ID: 20076812
[TBL] [Abstract][Full Text] [Related]
19. [Investigation of visceral hyperesthesia in irritable bowel syndrome].
Király A; Csizmadia C; Illés A; Undi S
Orv Hetil; 2006 Mar; 147(9):421-6. PubMed ID: 16619961
[TBL] [Abstract][Full Text] [Related]
20. A prospective assessment of bowel habit in irritable bowel syndrome in women: defining an alternator.
Drossman DA; Morris CB; Hu Y; Toner BB; Diamant N; Leserman J; Shetzline M; Dalton C; Bangdiwala SI
Gastroenterology; 2005 Mar; 128(3):580-9. PubMed ID: 15765393
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
